Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Pfizer's TALAPRO-2 study shows Talzenna + Xtandi significantly improves survival in mCRPC patients, with up to a 14-month OS ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

With a new treatment for prostate cancer in play, men with more aggressive forms of prostate cancer may have a more positive ...

At the forefront of advanced and holistic treatments, Mount Elizabeth Hospital uses a comprehensive team approach in treatments.

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

When cancer cells enter the male reproductive system, the prostate gland is in serious trouble. Nonetheless, advancements have significantly improved treatment, allowing for easier recovery among ...

In today's health-conscious world, men's wellness has gained unprecedented attention, particularly when it comes to prostate ...

The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.

Untreated prostate cancer can sometimes cause erectile dysfunction (ED). However, ED is more commonly associated with ...